Q&A on HIV PrEP: Episode 1 on Transgender Individuals and Racial and Ethnic Minority Men Who Have Sex With Men

In this episode, Raphael J. Landovitz, MD, MSc, and Hyman Scott, MD, MPH, discuss key considerations for PrEP uptake in transgender individuals and racial and ethnic minority men who have sex with men, including: Misconceptions about PrEP eligibility Strategies to improve lab monitoring on PrEP Leveraging patient navigators and clinic staff to expand PrEP accessData on PrEP efficacy in key populations (eg, transgender men, people who inject drugs)Considerations for prescribing on-demand and same-day PrEP Addressing healthcare professional hesitancy to prescribe PrEPUS Preventive Services Task Force PrEP guideline updatesBundling sexually transmitted infection services with PrEPFacultyRaphael J. Landovitz, MD, MSc<br />Professor of Medicine<br />Division of Infectious Diseases<br />David Geffen School of Medicine<br />University of California, Los Angeles<br />Director, UCLA Center for Clinical AIDS Co-Director, Center for HIV Identification, Prevention, and Treatment Services <br />Los Angeles, CaliforniaHyman Scott, MD<br />Assistant Clinical Professor<br />Department of Medicine<br />University of California, San Francisco<br />Clinical Research Medical Director<br />Bridge HIV<br />San Francisco Department of <br />Public Health<br />San Francisco, CaliforniaLink to full program: <br />https://bit.ly/3PZGYdR